Skip to content

Needle-knife fistulotomy (NKF) for primary biliary access in patients with choledocholithiasis; a *real world* prospective multicenter pilot study

Needle-knife fistulotomy (NKF) for primary biliary access in patients with choledocholithiasis; a *real world* prospective multicenter pilot study - INCISION

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56974
Enrollment
60
Registered
2024-08-27
Start date
2024-11-15
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis gallstones

Interventions

needle-knife fistulotomy as primary cannulation technique after hands-on training on an ex-vivo ERCP model provided by the researchers.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with an indication for ERCP with sphincterotomy (e.g. choledocholithiasis) - Sedation with administration of propofol or general anesthesia during ERCP - Naive papilla - Capable of written informed consent - Age >= 18 years

Exclusion criteria

Exclusion criteria: - Low risk of pancreatitis: (1) definite chronic pancreatitis according to M-ANNHEIM criteria (15), (2) previous sphincterotomy, and (3) routine biliary stent exchange. In case of a pancreatic duct intervention, chronic pancreatitis and previous sphincterotomy are not exclusion criteria - Acute pancreatitis, according to the Atlanta classification - Altered anatomy (defined as anatomical variations in which bile and/or pancreatic secretions (in case of pancreatic duct interventions) do not enter the duodenum by way of the ampulla of Vater (e.g., Roux-en-Y reconstruction, surgery for chronic pancreatitis) - Pregnancy - Severe liver disease (ascites) - Contraindications for rectal NSAIDs, including allergy, active gastrointestinal bleeding, ulcer disease, renal insufficiency (glomerular filtration rate

Design outcomes

Primary

MeasureTime frame
The primary outcome is safety and feasibility of NKF. Feasibility is defined as successful biliary cannulation via the fistulotomy. Safety is defined as absence of ERCP related complications (perforation, bleeding, post ERCP pancreatitis).

Secondary

MeasureTime frame
Secondary outcomes will include: - Individual components of the primary endpoint - Clinical success - Successful CBD stone removal - PD cannulation/contrast injection - Time from first contact with the papilla until successful cannulation - Total cannulation time and total procedure time - Other ERCP-related adverse events, such as cholangitis, cholecystitis and abscess within 30 days - Mortality within 30 days - Objective structured assessment of technical skills (OSATS) - Association between OSATS based graded performance on ex vivo model and learning curve (as measured by procedural time and outcome) in patients

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)